Compare · ALPS vs HIMS
ALPS vs HIMS
Side-by-side comparison of ALPS Group Inc (ALPS) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALPS and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.06B, about 110.5x ALPS ($54.9M).
- HIMS has been more active in the news (8 items in the past 4 weeks vs 3 for ALPS).
- HIMS has more recent analyst coverage (25 ratings vs 0 for ALPS).
- Company
- ALPS Group Inc
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- $54.9M
- $6.06B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 3
- 8
- Recent ratings
- 0
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest ALPS
- SEC Form 6-K filed by ALPS Group Inc
- Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
- SEC Form 6-K filed by ALPS Group Inc
- SEC Form 6-K filed by ALPS Group Inc
- SEC Form 6-K filed by ALPS Group Inc
- Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
- SEC Form 20-F filed by ALPS Group Inc
- SEC Form NT 20-F filed by ALPS Group Inc
- SEC Form 6-K filed by ALPS Group Inc
- Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia
Latest HIMS
- Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
- Hims & Hers Benefits Adds Grüns, Medjet, Tonal, and Viome for Whole-Body Health and Support When You Need It Most
- Chief Legal Officer Boughton Soleil sold $95,551 worth of shares (3,462 units at $27.60) as part of a pre-agreed trading plan (SEC Form 4)
- Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
- Chief Legal Officer Boughton Soleil sold $100,577 worth of shares (3,461 units at $29.06) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer